301033.SZ
Medprin Regenerative Medical Technologies Co., Ltd.
SZSE · C 制造业 · CN
CNY 53.76
+3.50%Sep 24, 2026, 09:54 UTC
Medprin Regenerative Medical Technologies obtained a Class III medical device registration certificate from the National Medical Products Administration for its self-developed oral absorbable repair membrane, valid until September 22, 2031.
Source:Sep 8, 2026, 08:14 UTC
Medprin Biotech announced that its absorbable hemostatic fluid gelatin has entered clinical trials as a Class III medical device for surgical hemostasis.
Source:Sep 3, 2026, 08:56 UTC
Shenzhen Kaiying Technology Co., Ltd., a shareholder holding more than 5% of Medprin Medical, completed its planned share reduction, selling 80,100 shares at an average price of 56.00 yuan per share during the period from August 7, 2026 to September 1, 2026, reducing its stake to 5.7185%.
Source:Jul 24, 2026, 11:37 UTC
Maipu Medical received regulatory approval for its share issuance and cash payment to acquire assets and raise matching funds.
Source: